ARDELYX is a startup based in Unknown, most recent round IPO, 2 tracked investors.
Based in Unknown, ARDELYX is a startup. Its most recent tracked round is IPO. Brouky records 2 investors associated with the company.
Ardelyx is a biopharmaceutical company focused on developing first-in-class medicines for patients with unmet medical needs, with pipeline programs and marketed therapies addressing chronic kidney disease with hyperphosphatemia and irritable bowel syndrome with constipation (IBS-C).
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.